Determined2Heal recently published the results of an "Evaluation of the ReWalk Computerized Exoskeleton for Patients with Spinal Cord Injury in Community Settings".
ReWalk Announces Launch of 522 Post-Market Study with Stanford University School of Medicine as Lead Investigator Site
The 522 study will follow 60 patients for one year, and will include as many as 15 centers across the United States.